Brandão Mariana, Bariani Riccardo, Rigato Ilaria, Bauce Barbara
Cardiology Department, Centro Hospitalar Vila Nova de Gaia/Espinho, 4430-000 Vila Nova de Gaia, Portugal.
Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, 35122 Padova, Italy.
J Clin Med. 2023 Apr 3;12(7):2660. doi: 10.3390/jcm12072660.
Desmoplakin (DSP) is a desmosomal protein that plays an essential role for cell-to-cell adhesion within the cardiomyocytes. The first association between genetic variants and the presence of a myocardial disease referred to patients with Carvajal syndrome. Since then, several reports have linked the gene to familial forms of arrhythmogenic (ACM) and dilated cardiomyopathies. Left-dominant ACM is the most common phenotype in individuals carrying variants. More recently, a new entity-"Desmoplakin cardiomyopathy"-was described as a distinct form of cardiomyopathy characterized by frequent left ventricular involvement with extensive fibrosis, high arrhythmic risk, and episodes of acute myocardial injury. The purpose of this review was to summarize the available evidence on DSP cardiomyopathy and to identify existing gaps in knowledge that need clarification from upcoming research.
桥粒斑蛋白(DSP)是一种桥粒蛋白,对心肌细胞间的细胞黏附起着至关重要的作用。基因变异与心肌病的首次关联涉及患有卡瓦哈尔综合征的患者。从那时起,有几份报告将该基因与致心律失常性心肌病(ACM)和扩张型心肌病的家族形式联系起来。左优势型ACM是携带该变异个体中最常见的表型。最近,一种新的实体——“桥粒斑蛋白心肌病”被描述为一种独特的心肌病形式,其特征是左心室频繁受累,伴有广泛纤维化、高心律失常风险和急性心肌损伤发作。本综述的目的是总结关于DSP心肌病的现有证据,并确定现有知识空白,这些空白需要未来研究加以阐明。